Altria
Summary
Altria Group, one of the largest tobacco companies in the U.S., faces significant legal and regulatory challenges primarily related to its $12.8 billion investment in Juul Labs and alleged conspiracy to target youth with vaping products. The company has been subject to multiple securities fraud class actions, antitrust litigation, and regulatory violations totaling over $1.2 billion in penalties since 2000.
Connected Entities
1 entitiesTimeline(10 events)
20 December 2018
Altria announces $12.8 billion acquisition of 35% stake in JUUL Labs, valuing the company at $38 billion
CNBC13 June 2019
U.S. House of Representatives launches investigation into Juul Labs and business deal with Altria
Wikipedia30 January 2020
Altria takes additional $4.1 billion impairment charge on JUUL investment, citing increased litigation
CNBC16 December 2021
Preliminary approval granted for $90 million securities fraud class action settlement
Pomerantz LLP24 February 2022
Administrative Law Judge dismisses FTC antitrust complaint against Altria and JUUL
Federal Trade Commission3 July 2023
FTC Commission vacates ALJ initial decision and dismisses complaint in case against Altria and Juul
Federal Trade Commission14 March 2024
Final approval granted for $235 million settlement resolving remaining JUUL-related litigation
Lieff Cabraser2 April 2025
Deutsche Bank downgrades Altria citing patent litigation risks with NJOY ACE products
News JournalDecision Log
- hash: 8kZhARek6qjVRmc7WEnM9nY77bt6u2EEEwogen8iMByW
This investigation is cryptographically anchored to the Solana blockchain (1 event). 8 of 8 cited source URLs have an Internet Archive snapshot.
model: claude-sonnet-4-20250514
generated: 4/17/2026, 3:04:43 AM
last updated: 7/24/2026, 4:29:00 PM
avoid.net — verified advice for a post-truth world